Status: current, Defined. Date: 04-Feb 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4523541000168112 | tozinameran (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4523551000168114 | tozinameran | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4523661000168112 | BNT162b2 mRNA (messenger ribonucleic acid) encoding SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) spike glycoprotein | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4523671000168118 | BNT162b2 mRNA encoding SARS-CoV-2 spike protein | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4655551000168116 | COVID-19 BNT162b2 mRNA vaccine | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| tozinameran | Is a | medicinal product | true | Inferred relationship | Some | ||
| tozinameran | has intended active ingredient | tozinameran | true | Inferred relationship | Some | 979706706 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| tozinameran injection, 0.45 mL vial | Is a | True | tozinameran | Inferred relationship | Some | |
| tozinameran injection, 1.3 mL vial | Is a | True | tozinameran | Inferred relationship | Some | |
| tozinameran 30 microgram/0.3 mL injection, 2.25 mL vial | Is a | True | tozinameran | Inferred relationship | Some | |
| tozinameran + riltozinameran | Is a | True | tozinameran | Inferred relationship | Some | |
| tozinameran + famtozinameran | Is a | True | tozinameran | Inferred relationship | Some | |
| tozinameran injection, 0.4 mL vial | Is a | True | tozinameran | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR